Topical Ivermectin in the Treatment of Papulopustular Rosacea: A Systematic Review of Evidence and Clinical Guideline Recommendations

[1] Anzengruber F(2017)Swiss S1 guideline for the treatment of rosacea J Eur Acad Dermatol Venereol 31 1775-1791

[2] Czernielewski J(2016)Canadian clinical practice guidelines for rosacea J Cutan Med Surg 20 432-445

[3] Conrad C(2016)Erythema of rosacea impairs quality of life: results of a meta-analysis Dermatol Ther (Heidelb) 6 237-247

[4] Asai Y(2015)Ivermectin: a review in rosacea Am J Clin Dermatol 16 447-452

[5] Tan J(2005)Ivermectin: pharmacology and application in dermatology Int J Dermatol 44 981-988

[6] Baibergenova A(2016)Patients with rosacea have increased risk of depression and anxiety disorders: a Danish nationwide cohort study Dermatology 232 208-213

[7] Bewley A(2011)Rosacea–global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group J Eur Acad Dermatol Venereol 25 188-200

[8] Fowler J(2017)Two consecutive standardized skin surface biopsies: an improved sampling method to evaluate Acta Derm Venereol 97 242-248

[9] Schöfer H(2005) density as a diagnostic tool for rosacea and demodicosis J Am Acad Dermatol 52 74-87

[10] Kerrouche N(1993)Demodicosis and rosacea: epidemiology and significance in daily dermatologic practice Br J Dermatol 128 650-659

[1] Anzengruber F(2017)Swiss S1 guideline for the treatment of rosacea J Eur Acad Dermatol Venereol 31 1775-1791

[2] Czernielewski J(2016)Canadian clinical practice guidelines for rosacea J Cutan Med Surg 20 432-445

[3] Conrad C(2016)Erythema of rosacea impairs quality of life: results of a meta-analysis Dermatol Ther (Heidelb) 6 237-247

[4] Asai Y(2015)Ivermectin: a review in rosacea Am J Clin Dermatol 16 447-452

[5] Tan J(2005)Ivermectin: pharmacology and application in dermatology Int J Dermatol 44 981-988

[6] Baibergenova A(2016)Patients with rosacea have increased risk of depression and anxiety disorders: a Danish nationwide cohort study Dermatology 232 208-213

[7] Bewley A(2011)Rosacea–global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group J Eur Acad Dermatol Venereol 25 188-200

[8] Fowler J(2017)Two consecutive standardized skin surface biopsies: an improved sampling method to evaluate Acta Derm Venereol 97 242-248

[9] Schöfer H(2005) density as a diagnostic tool for rosacea and demodicosis J Am Acad Dermatol 52 74-87

[10] Kerrouche N(1993)Demodicosis and rosacea: epidemiology and significance in daily dermatologic practice Br J Dermatol 128 650-659